BRIGHT MINDS BIOSCIENCES INC. Diluted Earnings Loss Per Share
BRIGHT MINDS BIOSCIENCES INC. (DRUG) reported Diluted Earnings Loss Per Share of -0.65 CAD/shares for the 12-month period ending 2024-09-30, per its 20-F filed 2024-12-31.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:DilutedEarningsLossPerShare · last filed 2024-12-31
| Period end | Diluted Earnings Loss Per Share 12 month | Diluted Earnings Loss Per Share 12 month as first filed |
|---|---|---|
| 2024-09-30 | -0.65 CAD/shares 20-F · filed 2024-12-31 | |
| 2023-09-30 | -1.98 CAD/shares 20-F · filed 2024-12-31 | |
| 2022-09-30 | -6.06 CAD/shares 20-F · filed 2024-12-31 | -1.21 CAD/shares 20-F · filed 2022-12-29 |
| 2021-09-30 | -4.82 CAD/shares 20-F · filed 2023-12-29 | -0.96 CAD/shares 20-F · filed 2022-12-29 |
| 2020-09-30 | -0.13 CAD/shares 20-F · filed 2022-12-29 |